Highlights from

ATS 2019

American Thoracic Society international conference

Dallas, USA 17-22 May 2019

Million-patient study reveals gaps in long-term adherence among various sub-populations

Men with sleep apnoea are 8.5% more likely to stay adherent on continuous positive airway pressure (CPAP) therapy than women, according to a study presented by Dr Jeff Armitstead (ResMed Science Center, Australia) [1].

The researchers examined de-identified data of 954,838 CPAP users from a remote monitoring network, who were registered for its patient engagement tool in the USA. The study found significant differences in 1-year adherence between people of different ages and disease severity levels:

  1. Overall adherence at 1 year was 70.4%.
  2. Men with sleep apnoea were 8.3% more likely to stay adherent on PAP therapy than women.
  3. People over age 60 were 7.3 percentage points more adherent than the entire study cohort (77.7% vs 70.4%).
  4. People with self-reported severe sleep apnoea (apnoea-hypopnoea index [AHI] ≥30/h) were 78% adherent at the 1-year mark, compared with 70.5% of those with self-reported moderate sleep apnoea (AHI 15-30/h), and 65% of those with mild sleep apnoea (AHI 5-15/h).

The study points to gaps in adherence to CPAP therapy for sleep apnoea indicating an unmet need for improved support, especially in women, younger patients, and those with mild disease.

  1. Armitstead JP. A2600, ATS 2019, 17-22 May, Dallas, USA.

The content and interpretation of these conference highlights are the views and comments of the speakers/authors.